Our data support this hypothesis; in our system, NG52-mediated PGK1 inhibition significantly reduced placental OS, accompanied by an increase in Keap1 dimerization and improved STZ-induced pregnancy outcomes in GDM mice. Here, PGK1 is linked to gestational diabetes.